Determining whether or not a MRSA infection is susceptible or resistant to a particular drug is an essential part of caring for MRSA infections, no matter where they occur or how serious they are. If you receive a prescription to treat MRSA, insist that your doctor discuss with you what names the drug is sold under, what drug family it belongs to -- and most important, what reasons your doctor has for believing that drug will be effective.This advice might be applicable to Methicillin-sensitive S. aureus (MSSA) infections too, considering her latest blog entry.
One of the repeated themes in the 50-year evolution of MRSA has been its ability — all staph's ability — to promiscuously swap and share the bits of DNA that confer resistance and enhance virulence.
We have also reported an increased number and severity of invasive cases, e.g. complicated pneumonia, osteomyelitis, pyomyositis, myositis and severe sepsis syndrome associated with the predominance of clone USA300 [9,14-18]. Similar observations have been described at other institutions across the United States [19]. Recent reports suggest that USA300 is more virulent than other MRSA strains . . .Sincere question: am I misreading you or these sources, or are these sources incorrect? Staph-related necrotizing pneumonia, pyomyositis, etc, typically occurred before penicillin use became widespread?
« Older Guillermo Del Toro is set to direct his version of... | The Appalachian Trail, beyond ... Newer »
This thread has been archived and is closed to new comments
posted by mccarty.tim at 6:17 PM on August 2, 2010